FDA Investigator Andrea D Charles Julien
Andrea D Charles Julien has conducted inspections on 21 sites in 1 countries as of 01 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
21
Last Inspection Date:
01 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Andrea D Charles Julien:
Anabel Veiga,
Bruce Quijano,
CDR Ileana Barreto Pettit,
Charles M Edwards,
Chyla T Hunter,
Cindy Laboy,
Clara E Santiago,
Courtney A Gilbert,
David P King,
Diana Ramirez,
Dillard H Woody, Jr,
Edwin J Gorney,
Eric R Holm,
Ernest A Clausnitzer,
Frances M Rivera,
Giovanna Serpa,
Hirshfield,
Howard A Webley,
Ivis L Negron,
James To Neal,
Jason P Aun,
Jennifer L Huntington,
Jennifer Lalama,
Jingbo Xiao,
Joanne E King,
John J Bernal,
Karissa J Mccaw,
Karl D Hezel,
Katherine A Bearss,
Katherine A Kellogg,
Katherine M Taylor,
Laura B Kennedy,
Lenora M Amason,
Leslie A Cartmill,
Linda K Matheny,
LT Tamara J Henderson,
Luz I Collado,
Marc Balzarini,
Marinee Flores Marrero,
Mary F Bodick,
Melanie G Warzala,
Michael C Lombardi,
Miguel A Martinez Perez,
Munoz,
Nicolas Riveratorres,
Ormond,
Pablo Feliciano,
Paul A Licata,
Rachel A Gomez,
Rachel A Peters,
Raymond A Lyn, Jr,
Reynolds,
Rodney W Lenger,
Sally Gopaul,
Sarah A Palmer,
Sharon Giamberini,
Sheri L Stephenson,
Siramad Sainz Trujillo,
Stacey A Meyer,
Steven J Rush,
William A Oetting,
Yazmith Guzman
Andrea D Charles Julien's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2013 | EIR | SOFGEN PHARMACEUTICALS LLC - EIR, 2013-08-16 |
August, 2013 | FDA 483 | SOFGEN PHARMACEUTICALS LLC - Form 483, 2013-08-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more